Clinical Trial Update: Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africa [Phase 2]

View source ↗

Summary

This is a completed Phase 2 proof-of-concept trial evaluating the MSP3-LSP malaria vaccine in Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MSP3-LSP vaccine (MSP3-LSP malaria vaccine)

Snippet

Sponsor: Vac4All | Conditions: Malaria | Phase 2 | Status: COMPLETED